In 2008, the Washington AIDS Partnership initiated the HIV Medication Pipeline Project, a public-private partnership with the D.C. government’s HIV/AIDS, Hepatitis, STD, and TB Administration (HAHSTA). The goal of this project was to expand the HIV medication safety-net and improve advanced planning for D.C.’s AIDS Drug Assistance Program (ADAP). ADAP is a federal program that provides funding to states for HIV medication for low-income individuals with HIV who have limited or no access to prescription drugs. Without this public-private partnership, the D.C. government would have forfeited $5.8 million in federal ADAP funding. The project goal was to examine best practices in the field and D.C.’s drug procurement and delivery process, and use project funds to purchase much needed HIV medications for low income individuals living with HIV.
The Partnership and HAHSTA worked with John Snow, Inc. (JSI) to conduct an assessment of current D.C. ADAP policy, financing, structure, functions, and performance of the D.C. ADAP supply chain for HIV medications. JSI also developed forecasting methodology for future projections.
Through this project, $5.59 million was used in Pipeline funds to purchase more than 14,000 units of HIV medication for low-income D.C. residents living with HIV.